• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TYP
Click for more information
0.00% 2.0¢

TRYPTAMINE THERAPEUTICS LIMITED

Market Cap $21.78M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology... Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on the development of an advanced and scalable intravenous-infused psilocin formulation, which can be used in conjunction with psychotherapy to address significant unmet medical needs. It is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. It intends to accomplish this through the development of an IV infusion of psilocin (the active metabolite of psilocybin). Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. The Company is engaged in pursuing Phase II clinical trials using its psilocybin and psilocin-based drug products for chronic pain and eating disorders. The Company's pipeline products include TRP-8803 and TRP-8802.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
TYP
TYP - Research, Results, Valuations, and Comparisons 		11:58 6 1.3K
11:58 Last post  mcmurraj Comments Created with Sketch.  6  Views Created with Sketch.  1.3K 
TYP
Ann: Positive Phase 2a fibromyalgia results across all patients 		12/08/24 4 2.0K
12/08/24 Last post  dsa69 Comments Created with Sketch.  4  Views Created with Sketch.  2.0K 
TYP
Ann: Trading Halt 		09/08/24 5 2.2K
09/08/24 Last post  sle Comments Created with Sketch.  5  Views Created with Sketch.  2.2K 
TYP
News: TYP Tryptamine Therapeutics Seeks Trading Halt 		07/08/24 0 183
07/08/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  183 
TYP
Ann: Quarterly Activities Report and Appendix 4C 		31/07/24 0 444
31/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  444 
TYP
Ann: TechKnow Invest Roadshow presentation and livestream links 		30/07/24 0 456
30/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  456 
TYP
Ann: Appointment of Professor Phillipa Hay to TYPs SAB 		30/07/24 0 352
30/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  352 
TYP
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow) 		30/07/24 0 131
30/07/24 Last post  DTasker76 Comments Created with Sketch.  0  Views Created with Sketch.  131 

See All Discussions arrow Created with Sketch.

Timeline

Positive Phase 2a fibromyalgia results across all patients
12 Aug 09:30
 
Trading Halt
07 Aug 17:37
 
Quarterly Activities Report and Appendix 4C
31 Jul 08:44
 
TechKnow Invest Roadshow presentation and livestream links
30 Jul 08:52
 
Appointment of Professor Phillipa Hay to TYPs SAB
30 Jul 08:39
 
Psychiatry professor David Castle appointed to TYPs SAB
29 Jul 09:29
 
View More arrow Created with Sketch.

Featured News

RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
(20min delay)
Last
2.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $21.78M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 597934 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 250000 1
View Market Depth
Last trade - 16.12pm 23/08/2024 (20 minute delay) ?
TYP (ASX) Chart

Top Stories

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

IPH Ltd has raised $100 million in an institutional placement to support the acquisition, while also launching a share purchase plan.
Raiden gears up for exploration in final quarter of 2024 Raiden Resources Ltd - which is exploration for a multiplicity of minerals in the Pilbara region of WA - is looking ahead to a busy schedule.
Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings A southward cluster of outcropping pegmatites on-site Chariot Corporation's (ASX:CC9) flagship Black Mountain hard rock lithium project has led management and geotechs to sign off on a promising future drilling target for the company as exploration on-site gathers pace.
The business of sport: Warren Tredrea's take on this week's news Former Port Adelaide AFL star – turned media personality – Warren Tredrea and co-host Jack Hudson explore money in sport.
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.

Featured News

NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.